Team Member

Dr. Gollob obtained an undergraduate degree in molecular genetics at the University of Toronto, graduating as a Gold Medalist in 1990. He then entered the field of medicine and is now an arrhythmia specialist with a clinical practice at PACE Cardiology and the Toronto General Hospital.

He also has an appointment in the Department of Physiology at the University of Toronto. Dr. Gollob’s clinical practice is focused on genetic-based arrhythmia and cardiomyopathy syndromes, including atrial fibrillation, Long QT syndrome, Brugada Syndrome, CPVT, Short QT syndrome, unexplained sudden death, arrhythmogenic cardiomyopathies and hypertrophic cardiomyopathy.

Dr. Gollob’s research group studies the genetic and physiological basis of sudden death syndromes, the common arrhythmia of atrial fibrillation, and cytoskeletal or metabolic based cardiomyopathy conditions. His research laboratory has identified genes causative for sudden death and atrial fibrillation, and he has published his research in high impact journals including the New England Journal of Medicine, Circulation and Nature.

He has Chaired on behalf of the Canadian Cardiovascular Society the first guideline document outlining the appropriate use of genetic testing for cardiac diseases associated with a risk of sudden death. He is currently the Chair of the National Institutes of Health funded Clinical Genome Resource Channelopathy Working Group which has led to recent publications clarifying the genetic causes of Long QT syndrome and Brugada Syndrome.

Dr. Gollob holds peer-reviewed research funding from the Canadian Institutes for Health Research (CIHR).

View publications